EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 93 filers reported holding EIDOS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $23,501,000 | +237.3% | 178,608 | +29.5% | 0.06% | +181.8% |
| Q3 2020 | $6,968,000 | -4.2% | 137,900 | -9.6% | 0.02% | -12.0% |
| Q2 2020 | $7,273,000 | -48.3% | 152,564 | -46.9% | 0.02% | -59.7% |
| Q1 2020 | $14,081,000 | -31.6% | 287,426 | -19.9% | 0.06% | -10.1% |
| Q4 2019 | $20,581,000 | +9.4% | 358,611 | -31.4% | 0.07% | +7.8% |
| Q3 2019 | $18,813,000 | +5.4% | 523,015 | -9.0% | 0.06% | +10.3% |
| Q2 2019 | $17,854,000 | +164.2% | 574,466 | +99.3% | 0.06% | +152.2% |
| Q1 2019 | $6,759,000 | – | 288,222 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,123,630 | $56,777,000 | 18.14% |
| Board of Trustees of The Leland Stanford Junior University | 265,670 | $13,425,000 | 5.17% |
| Opaleye Management Inc. | 315,550 | $15,945,000 | 3.12% |
| RA Capital Management | 2,163,271 | $109,310,000 | 2.00% |
| Cormorant Asset Management, LP | 993,185 | $50,186,000 | 1.93% |
| Parkman Healthcare Partners LLC | 41,091 | $2,076,000 | 0.55% |
| Perceptive Advisors | 686,922 | $34,710,000 | 0.51% |
| Redmile Group, LLC | 466,205 | $23,557,000 | 0.43% |
| Eventide Asset Management | 317,417 | $16,039,000 | 0.31% |
| Ikarian Capital, LLC | 63,011 | $3,184,000 | 0.23% |